Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss
暂无分享,去创建一个
A. Font | U. de Giorgi | S. Bracarda | J. D. de Bono | C. Massard | S. Gendreau | V. Jinga | R. Riisnaes | D. Rodrigues | Premal H. Patel | D. Maslyar | K. Shih | G. Rădăvoi | W. Chan | J. A. Arranz Arija | N. Xu | Han Ma | G. D. Radavoi